BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24799984)

  • 1. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.
    Castiella A; Zapata E; Lucena MI; Andrade RJ
    World J Hepatol; 2014 Apr; 6(4):160-8. PubMed ID: 24799984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
    Weber S; Gerbes AL
    Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Liver Injury Induced by Olmesartan Mediated by Autoimmune-Like Mechanism: A Case Report.
    de la Torre-Aláez M; Iñarrairaegui M
    Eur J Case Rep Intern Med; 2020; 7(1):001407. PubMed ID: 32015975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced autoimmune-like liver injury].
    Weber S
    Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
    Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
    J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.
    Kuzu UB; Öztaş E; Turhan N; Saygili F; Suna N; Yildiz H; Kaplan M; Akpinar MY; Akdoğan M; Kaçar S; Kiliç ZM; Köksal AŞ; Ödemiş B; Kayaçetin E
    Hepatol Res; 2016 Apr; 46(4):277-91. PubMed ID: 25926402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
    Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
    Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
    Sebode M; Schulz L; Lohse AW
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
    de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
    García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
    Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
    Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
    J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype.
    Lammert C; Zhu C; Lian Y; Raman I; Eckert G; Li QZ; Chalasani N
    Hepatol Commun; 2020 Nov; 4(11):1651-1663. PubMed ID: 33163835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 14. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
    Weber S; Benesic A; Rotter I; Gerbes AL
    Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases.
    Febres-Aldana CA; Alghamdi S; Krishnamurthy K; Poppiti RJ
    J Clin Transl Hepatol; 2019 Mar; 7(1):21-26. PubMed ID: 30944815
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles.
    Stephens C; Castiella A; Gomez-Moreno EM; Otazua P; López-Nevot MÁ; Zapata E; Ortega-Alonso A; Ruiz-Cabello F; Medina-Cáliz I; Robles-Díaz M; Soriano G; Roman E; Hallal H; Moreno-Planas JM; Prieto M; Andrade RJ; Lucena MI
    Pharmacogenet Genomics; 2016 Sep; 26(9):414-22. PubMed ID: 27206238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
    Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
    Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
    Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
    J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling for drug-induced liver injury with autoantibodies.
    Han YZ; Ma ZT; Zhou MX; Niu M; Zhao X; Guo YM; Song XH; Lu YW; Bai ZF; Li Z; Gao H; Zhao YK; Wang JB; Xiao XH; Jing J
    Int Immunopharmacol; 2022 Oct; 111():109084. PubMed ID: 35932613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.